Panion & Bf Biotech Inc. (TPE:1760)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.40
-1.40 (-2.01%)
Apr 29, 2026, 1:30 PM CST
1.03%
Market Cap 5.98B
Revenue (ttm) 2.06B
Net Income (ttm) 190.17M
Shares Out 85.74M
EPS (ttm) 2.21
PE Ratio 31.58
Forward PE n/a
Dividend 2.00 (3.15%)
Ex-Dividend Date Jun 12, 2025
Volume 3,439,337
Average Volume 376,530
Open 76.40
Previous Close 69.80
Day's Range 68.40 - 76.40
52-Week Range 58.00 - 89.90
Beta -0.04
RSI 64.92
Earnings Date May 11, 2026

About Panion & Bf Biotech

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygien... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1976
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1760
Full Company Profile

Financial Performance

In 2025, Panion & Bf Biotech's revenue was 2.06 billion, an increase of 1.66% compared to the previous year's 2.03 billion. Earnings were 190.17 million, an increase of 52.72%.

Financial Statements

News

There is no news available yet.